High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations
用于转录和染色质扰动的紧凑工具的高通量开发和表征
基本信息
- 批准号:10632140
- 负责人:
- 金额:$ 99.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-09 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:BindingBiologicalBiological AssayCRISPR interferenceCRISPR-mediated transcriptional activationCatalogsCellsChromatinClustered Regularly Interspaced Short Palindromic RepeatsCodeComplexDNADNA Binding DomainDNA MaintenanceDNA Modification ProcessDNA Sequence AlterationDNA-Binding ProteinsData SetDevelopmentDiseaseElementsEngineeringEnhancersEpigenetic ProcessExhibitsFutureGene ActivationGene ExpressionGene SilencingGenesGeneticGenetic ScreeningGenetic TranscriptionGenomeGenomicsHumanHuman GenomeKnock-outLabelLearningLibrariesMaintenanceMapsMeasuresMemoryMethyltransferaseMolecularMolecular ProfilingPathway interactionsPropertyProteinsRegulator GenesRegulatory ElementReporterReporter GenesRepressed MemoryResourcesSystemTechnologyTertiary Protein StructureTestingTimeTranscriptional ActivationUntranslated RNAViralViral ProteinsWorkYeastscell typechromatin modificationcofactorepigenetic memoryepigenetic silencingepigenomeepigenomicsexperimental studygene therapygenetic manipulationgenome-widegenomic locushigh throughput screeninghistone modificationhuman diseaseimprovedinterestnanobodiesnovelpromoterrecruitscreeningsynthetic proteintooltranscription factor
项目摘要
PROJECT SUMMARY
Genome-wide molecular profiling of dynamic DNA and chromatin modifications across diverse cell and disease
states have resulted in comprehensive catalogs of putative non-coding regulatory elements in the human
genome. Perturbation experiments are now critical to learn the causal functions of the DNA & histone
modifications at these genomic elements. However, existing tools to manipulate gene expression and chromatin
state suffer from partial or transient effects, are large and thus difficult to deliver, and exhibit high variability
across loci and cell types. These tools are currently drawn from a tiny fraction of the thousands of natural
chromatin regulatory complexes. A more complete toolbox of compact, efficient domains capable of
manipulating a broad range of chromatin pathways will transform our ability to determine the causal
function of particular chromatin modifications across the human genome and to control gene
expression.
Here, we propose to systematically and comprehensively measure the gene expression effects of
recruiting chromatin regulators and transcription factor protein domains that can interface with human chromatin
- a critical missing dataset. This is made possible by our recent development of the first high-throughput protein
domain recruitment assay in human cells, capable of measuring activity for tens of thousands of effector domains
simultaneously (Tycko et al, bioRxiv 2020). Using this system, we will recruit-and-release effector domains from
the promoter, wait, and then measure the magnitude and permanence of transcriptional silencing or activation
at a reporter locus. We will characterize thousands of domains drawn from human and viral chromatin and gene
regulators. In addition, we will create orthogonal nanobody libraries selected to recruit endogenous chromatin
regulators. We will then measure the function of these domains at a panel of endogenous genomic loci chosen
to represent diverse chromatin states. Finally, we will use genetic screens and epigenomic mapping assays to
determine the molecular networks that underpin the functions of these novel effectors. Therefore, we will create
and share a detailed resource of experimentally-measured, compact, efficient domains that can be fused onto
DNA-binding proteins in order to recruit desired chromatin regulatory complexes to act upon a genomic element.
At the same time, this study will provide detailed functional properties for all human transcriptional and chromatin
regulatory domains, serving as a starting point for future work on understanding the disease implications of
genetic mutations in the coding sequence of these regulators. Further, it will identify novel epigenome and
transcriptional effector domains that can impart permanent epigenetic memory, and identify combinations of
domains to impart a range of chromatin states not currently accessible with available perturbation tools. These
pathway-specific perturbation technologies will be critical to probe the function of the varied chromatin states at
regulatory elements that are currently being discovered and studied across diverse genomic loci and cell types.
项目摘要
动态DNA和染色质修饰的各种细胞和疾病的动态DNA和染色质修饰的分子分析
国家导致人类推定的非编码调节元素的全面目录
基因组。扰动实验现在对于学习DNA和组蛋白的因果功能至关重要
这些基因组元素的修改。但是,现有的操纵基因表达和染色质的工具
状态遭受部分或瞬态影响,很大,因此很难传递,并且表现出很高的可变性
跨基因座和细胞类型。这些工具目前是从数千天然中的一小部分中汲取的
染色质调节复合物。一个更完整的紧凑,高效域的工具箱
操纵广泛的染色质途径将改变我们确定因果关系的能力
在人基因组中特定的染色质修饰并控制基因的功能
表达。
在这里,我们建议系统,全面地测量
可以与人染色质接口
- 严重缺少的数据集。我们最近的第一个高通量蛋白的开发使它成为可能
人类细胞中的域募集分析,能够测量成千上万的效应域的活性
同时(Tycko等人,Biorxiv 2020)。使用此系统,我们将从
启动子,等待,然后测量转录沉默或激活的幅度和永久性
在记者基因座。我们将表征从人类和病毒染色质和基因中绘制的数千个域
监管机构。此外,我们将创建正交纳米库库,以募集内源性染色质
监管机构。然后,我们将测量这些域的功能
代表各种染色质状态。最后,我们将使用遗传筛选和表观基因组映射测定
确定支撑这些新型效应子功能的分子网络。因此,我们将创建
并共享可以融合到的实验测量,紧凑,高效的域的详细资源
DNA结合蛋白是为了募集所需的染色质调节复合物以作用于基因组元素。
同时,这项研究将为所有人类转录和染色质提供详细的功能特性
监管领域,是理解疾病影响的未来工作的起点
这些调节剂的编码序列中的遗传突变。此外,它将确定新颖的表观基因组和
转录效应子域,可以赋予永久表观遗传记忆,并确定
赋予一系列染色质状态的域目前无法使用可用的扰动工具访问。这些
途径特异性扰动技术对于探测各种染色质状态的功能至关重要
目前正在各种基因组基因组和细胞类型中发现和研究的调节元素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL C BASSIK其他文献
MICHAEL C BASSIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL C BASSIK', 18)}}的其他基金
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
项目3:控制乳腺癌进展和耐药因素的系统表征
- 批准号:
10704691 - 财政年份:2021
- 资助金额:
$ 99.26万 - 项目类别:
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
项目3:控制乳腺癌进展和耐药因素的系统表征
- 批准号:
10272391 - 财政年份:2021
- 资助金额:
$ 99.26万 - 项目类别:
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
项目3:控制乳腺癌进展和耐药因素的系统表征
- 批准号:
10911510 - 财政年份:2021
- 资助金额:
$ 99.26万 - 项目类别:
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations
用于转录和染色质扰动的紧凑工具的高通量开发和表征
- 批准号:
10276866 - 财政年份:2021
- 资助金额:
$ 99.26万 - 项目类别:
High-throughput systematic characterization of regulatory element function
调控元件功能的高通量系统表征
- 批准号:
10238366 - 财政年份:2020
- 资助金额:
$ 99.26万 - 项目类别:
Development of novel protein-based therapeutics for lung cancer
开发基于蛋白质的新型肺癌疗法
- 批准号:
10373026 - 财政年份:2018
- 资助金额:
$ 99.26万 - 项目类别:
Development of novel protein-based therapeutics for lung cancer
开发基于蛋白质的新型肺癌疗法
- 批准号:
10133002 - 财政年份:2018
- 资助金额:
$ 99.26万 - 项目类别:
Development of novel protein-based therapeutics for lung cancer
开发基于蛋白质的新型肺癌疗法
- 批准号:
9894638 - 财政年份:2018
- 资助金额:
$ 99.26万 - 项目类别:
High-throughput systematic characterization of regulatory element function
调控元件功能的高通量系统表征
- 批准号:
9247643 - 财政年份:2017
- 资助金额:
$ 99.26万 - 项目类别:
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
使用蛋白质相互作用网络和组合筛选来靶向 KRAS 驱动的癌症
- 批准号:
9315124 - 财政年份:2015
- 资助金额:
$ 99.26万 - 项目类别:
相似国自然基金
基于Bacillus subtilis 细胞传感器介导的肠道环境中结直肠癌相关生物标志物的动态检测策略
- 批准号:82372355
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CRISPR传感技术对稻田微生物甲基汞关键基因的检测机制研究
- 批准号:42377456
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于微流控芯片的赤潮微藻及其生物毒素同步快速定量检测研究
- 批准号:42307568
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
一种用于生物呼吸标记物检测的中红外全固态超短脉冲激光器的研究
- 批准号:62305188
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于镍纳米粒子催化新型生物传感器研制及应用于中药残留检测
- 批准号:82360857
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 99.26万 - 项目类别:
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 99.26万 - 项目类别:
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
- 批准号:
10749672 - 财政年份:2024
- 资助金额:
$ 99.26万 - 项目类别:
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 99.26万 - 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 99.26万 - 项目类别: